These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28724512)

  • 1. The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study.
    Desteghe L; Kluts K; Vijgen J; Koopman P; Dilling-Boer D; Schurmans J; Dendale P; Heidbuchel H
    JMIR Mhealth Uhealth; 2017 Jul; 5(7):e98. PubMed ID: 28724512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Smartphone App to Improve Oral Anticoagulation Adherence in Patients With Atrial Fibrillation: Prospective Observational Study.
    Senoo K; Miki T; Ohkura T; Iwakoshi H; Nishimura T; Shiraishi H; Teramukai S; Matoba S
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e30807. PubMed ID: 34894626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Usability and Usefulness of a Mobile App for Atrial Fibrillation Using Qualitative Methods: Exploratory Pilot Study.
    Hirschey J; Bane S; Mansour M; Sperber J; Agboola S; Kvedar J; Jethwani K
    JMIR Hum Factors; 2018 Mar; 5(1):e13. PubMed ID: 29549073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF).
    Yoon M; Park JJ; Hur T; Hua CH; Shim CY; Yoo BS; Cho HJ; Lee S; Kim HM; Kim JH; Lee S; Choi DJ
    Front Cardiovasc Med; 2023; 10():1130216. PubMed ID: 37324622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists.
    Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A
    Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacy-based study of adherence to non-vitamin K antagonist oral anticoagulants.
    Capiau A; Mehuys E; Van Tongelen I; Christiaens T; De Sutter A; Steurbaut S; Moudallel S; Rydant S; Vrijens B; de Backer TLM; Boussery K
    Heart; 2020 Nov; 106(22):1740-1746. PubMed ID: 32576607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing frequency important?
    Hwang HJ; Sohn IS; Jin ES; Bae YJ
    PLoS One; 2023; 18(3):e0283478. PubMed ID: 36996134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation.
    Lee SR; Lee YS; Park JS; Cha MJ; Kim TH; Park J; Park JK; Lee JM; Kang KW; Shim J; Uhm JS; Kim J; Kim C; Kim JB; Park HW; Joung B; Choi EK
    Yonsei Med J; 2019 Mar; 60(3):277-284. PubMed ID: 30799590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study.
    Zhang C; Pan MM; Wang N; Wang WW; Li Z; Gu ZC; Lin HW
    Eur J Clin Pharmacol; 2022 Feb; 78(2):293-304. PubMed ID: 34671819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Alfalfa App in the management of oral anticoagulation in patients with atrial fibrillation: a multicenter randomized controlled trial.
    Xu W; Huang X; Lin Q; Wu T; Guan C; Lv M; Hu W; Dai H; Chen P; Li M; Zhang F; Zhang J
    BMC Med Inform Decis Mak; 2024 Oct; 24(1):294. PubMed ID: 39385171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
    Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
    Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
    Shiyovich A; Shalev V; Chodick G; Tirosh M; Katz A; Klar MM; Shuvy M; Pereg D; Minha S
    BMC Cardiovasc Disord; 2021 Oct; 21(1):493. PubMed ID: 34645389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation.
    Desteghe L; Vijgen J; Koopman P; Dilling-Boer D; Schurmans J; Dendale P; Heidbuchel H
    Eur Heart J; 2018 Apr; 39(16):1394-1403. PubMed ID: 29300888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
    Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of minor bleeds on confidence in anticoagulation therapy, adherence to treatment and quality of life in patients using a non-vitamin K antagonist oral anticoagulant for atrial fibrillation.
    Mitrovic D; Veeger N; van Roon E
    Curr Med Res Opin; 2022 Sep; 38(9):1485-1488. PubMed ID: 35656940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study.
    Grymonprez M; Steurbaut S; Capiau A; Vauterin D; Van Vaerenbergh F; Mehuys E; Boussery K; De Backer TL; Lahousse L
    Cardiovasc Drugs Ther; 2023 Sep; ():. PubMed ID: 37707648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort study.
    Lin SM; Liu PP; Tu YK; Lai EC; Yeh JI; Hsu JY; Munir KM; Peng CC; Huang HK; Loh CH
    Cardiovasc Diabetol; 2023 Jan; 22(1):1. PubMed ID: 36609317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
    Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE
    J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.